epidermal growth factor receptor

It’s always a good day when a new treatment, especially one for lung cancer, becomes available. It’s even better when the drug trial was stopped early because the results were so clear. Though overshadowed in the headlines because the FDA approved it and gave emergency use authorization to Moderna’s Covid-19 vaccine on the same day,